Did you know that antibody-drug conjugates (ADCs) targeting Trop2 have demonstrated significant clinical potential for patients with TNBC?

Credit available for this activity expires: 4/8/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/front-antibody-drug-conjugates-shifting-paradigm-metastatic-2026a1000a9z?ecd=bdc_podcast_libsyn_mscpedu

Your patient asks, "Will switching to a biosimilar make my disease worse?" Learn how to confidently address their concerns.

Credit available for this activity expires: 4/7/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003282?ecd=bdc_podcast_libsyn_mscpedu

Did you know prior CDK4/6 duration may be prognostic for identifying patients more likely to benefit from single-agent oral SERDs?

Credit available for this activity expires: 04/07/2027
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/enhancing-clinical-understanding-oral-serd-based-therapies-2026a1000a46?ecd=bdc_podcast_libsyn_mscpedu

Optimize every trial: Discover how strategic medication selection clarifies the surgical path and improves patient outcomes before intervention.

Credit available for this activity expires: 04/02/2027
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/maximizing-therapeutic-efficacy-prior-epilepsy-surgery-2026a10009oz?ecd=bdc_podcast_libsyn_mscpedu

Do you know what to test for in your patients with CRC?

Credit available for this activity expires: 3/30/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/expanding-actionability-crucial-biomarkers-your-community-2026a10009al?ecd=bdc_podcast_libsyn_mscped

Do you know the next best steps for a patient with persistent gastroesophageal reflux disease (GERD) symptoms?

Credit available for this activity expires: 3/30/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/identifying-suboptimally-managed-erosive-esophagitis-2026a100096o?ecd=bdc_podcast_libsyn_mscped

Get the latest updates on HER2-mutated NSCLC.

Credit available for this activity expires: 3/30/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/steps-personalized-and-collaborative-decision-making-her2-2026a10007ur?ecd=bdc_podcast_libsyn_mscped

Are you familiar with the most common treatment-related events of emerging HER2-targeted therapies for gastroesophageal adenocarcinoma (GEA)?

Credit available for this activity expires: 3/30/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/nurse-view-evolution-anti-her2-therapies-gastroesophageal-2026a100096j?ecd=bdc_podcast_libsyn_mscpedu